Business Description
Shandong Keyuan Pharmaceutical Co Ltd
ISIN : CNE1000061V8
Share Class Description:
SZSE:301281: Class ACompare
Compare
Traded in other countries / regions
301281.China IPO Date
2023-04-04Description
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and their preparations.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | 5.89 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 12.94 | |||||
| Beneish M-Score | -0.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.7 | |||||
| 3-Year EBITDA Growth Rate | -5.2 | |||||
| 3-Year EPS without NRI Growth Rate | -9 | |||||
| 3-Year Book Growth Rate | 43 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 94.58 | |||||
| 9-Day RSI | 85.74 | |||||
| 14-Day RSI | 76.61 | |||||
| 6-1 Month Momentum % | -22.91 | |||||
| 12-1 Month Momentum % | -62.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.72 | |||||
| Quick Ratio | 5.77 | |||||
| Cash Ratio | 4.74 | |||||
| Days Inventory | 133.81 | |||||
| Days Sales Outstanding | 41.91 | |||||
| Days Payable | 68.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.23 | |||||
| Dividend Payout Ratio | 0.52 | |||||
| Forward Dividend Yield % | 1.23 | |||||
| 5-Year Yield-on-Cost % | 1.23 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.32 | |||||
| Operating Margin % | 10.95 | |||||
| Net Margin % | 13.46 | |||||
| FCF Margin % | -39.04 | |||||
| ROE % | 4.66 | |||||
| ROA % | 4.23 | |||||
| ROIC % | 5.91 | |||||
| ROC (Joel Greenblatt) % | 9.42 | |||||
| ROCE % | 3.72 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 43.94 | |||||
| PE Ratio without NRI | 42.04 | |||||
| Price-to-Owner-Earnings | 21.56 | |||||
| PEG Ratio | 2.9 | |||||
| PS Ratio | 5.72 | |||||
| PB Ratio | 1.98 | |||||
| Price-to-Tangible-Book | 2.12 | |||||
| Price-to-Operating-Cash-Flow | 77.52 | |||||
| EV-to-EBIT | 53.4 | |||||
| EV-to-EBITDA | 53.4 | |||||
| EV-to-Revenue | 5.85 | |||||
| EV-to-FCF | -14.97 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.63 | |||||
| Price-to-Graham-Number | 1.99 | |||||
| Price-to-Net-Current-Asset-Value | 4.58 | |||||
| Price-to-Net-Cash | 7.22 | |||||
| Earnings Yield (Greenblatt) % | 1.87 | |||||
| FCF Yield % | -6.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Keyuan Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 460.252 | ||
| EPS (TTM) (Â¥) | 0.554 | ||
| Beta | 0 | ||
| Volatility % | 39 | ||
| 14-Day RSI | 76.61 | ||
| 14-Day ATR (Â¥) | 0.600963 | ||
| 20-Day SMA (Â¥) | 21.292 | ||
| 12-1 Month Momentum % | -62.33 | ||
| 52-Week Range (Â¥) | 18.52 - 47.96 | ||
| Shares Outstanding (Mil) | 108.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Keyuan Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Keyuan Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Keyuan Pharmaceutical Co Ltd Frequently Asked Questions
What is Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281)'s stock price today?
The current price of SZSE:301281 is ¥24.34. The 52 week high of SZSE:301281 is ¥47.96 and 52 week low is ¥18.52.
When is next earnings date of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281)?
The next earnings date of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) is .
Does Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) is 1.23% (As of Today), Highest Dividend Payout Ratio of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) was 0.63. The lowest was 0.52. And the median was 0.63. The  Forward Dividend Yield % of Shandong Keyuan Pharmaceutical Co Ltd(SZSE:301281) is 1.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers